Related Experiment Video
Updated: Jun 30, 2026

07:20
Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Phytotherapy versus hormonal therapy for postmenopausal bone loss: a meta-analysis.
1School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. xumin@hkbu.edu.hk
Summary
Phytotherapy shows comparable bone mineral density effects to hormonal therapy for postmenopausal bone loss. It offers a safer alternative, with significantly fewer side effects like uterine bleeding and breast pain.
Area of Science:
- Integrative Medicine
- Bone Health
- Menopause Research
Background:
- Postmenopausal osteoporosis is a significant health concern.
- Hormonal therapy is a common treatment but carries adverse effects.
- Phytotherapy presents a potential alternative for managing bone loss.
Purpose of the Study:
- To compare the efficacy and safety of phytotherapy versus hormonal therapy for postmenopausal bone loss.
- To assess the quality of existing phytotherapy clinical trials.
- To identify commonly used herbs in phytotherapy for bone loss.
Main Methods:
- Meta-analysis of 14 randomized controlled trials (780 patients).
- Quality assessment of trials using Jadad's scale.
- Data synthesis and meta-analysis using Revman 5.0 software.
Main Results:
- No significant difference in bone mineral density (BMD) between phytotherapy and hormonal therapy.
- Phytotherapy group had significantly lower incidence of uterine bleeding and breast pain.
- Four of the 14 trials were graded as high quality.
Conclusions:
- Phytotherapy demonstrates comparable efficacy to hormonal therapy in improving BMD.
- Phytotherapy appears to be a safer treatment option for postmenopausal bone loss.
- Further high-quality trials are recommended to confirm these findings.
Related Concept Videos
Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...